Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer

Fudan University · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
breastcancer
breast cancer, hr positive, her2 positive metastatic breast cancer, dalpiciclib, fulvestrant, trastuzumab and pertuzumab, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 806269
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.